Surgical Bleeding
📧 Sign up to get email alerts when something new happens for Surgical Bleeding.
Sign up freeTop drugs studied for this disease
-
EMA safety_alert · 2025-10-31Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27 - 30 October 2025
The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) agreed to issue a safety communication to healthcare professionals about inject…
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: Safety and Efficacy of WoundClot Surgical [NA]
A completed clinical trial evaluated the safety and efficacy of WoundClot Surgical for managing surgical bleeding.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Topical Raplixa for Surgical Bleeding in Children [Phase 2]
Phase 2 trial update for topical Raplixa in surgical bleeding outcomes in children; study terminated with results posted.
-
EMA withdrawal · 2018-10-10EMA Withdrawn: Raplixa (human fibrinogen;human thrombin) — Mallinckrodt Pharmaceuticals Ireland Limited
Raplixa, a human fibrinogen and human thrombin product, has been withdrawn from the market by Mallinckrodt Pharmaceuticals Ireland Limited.
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Hematopoietic Stem Cell Transplantation [Phase 2]
A Phase 2 trial evaluating the efficacy and safety of activated recombinant human factor VII for treating bleeding after hematopoietic stem …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.